Miracle Light Venture
Overview
Miracle Light Venture is the corporate venture capital arm of BGI Genomics and is based in Shenzhen, China. The firm focuses on early-stage investments in the life sciences, genomics, and healthcare sectors. It also operates the Miracle Light life science accelerator, an innovation and investment platform initiated by BGI Group. The venture fund began investing at the end of 2017 and has invested in startups including Neurophth, JunHui Biotech, and Genewell.
Portfolio Companies
2
Website
miracle-light.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neurophth | Aug 2018 | Angel | Lead |
| FlashDx Inc. | Jan 2019 | Angel | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Miracle Light Venture based?
Miracle Light Venture is headquartered in Shenzhen, Guangdong, China.
When was Miracle Light Venture founded?
Founding year information for Miracle Light Venture is not publicly available.
How many portfolio companies does Miracle Light Venture have?
Miracle Light Venture has 2 portfolio companies in Caplight's dataset.
What are some companies in Miracle Light Venture's portfolio?
Portfolio companies visible on Caplight include Neurophth, FlashDx Inc..
What was Miracle Light Venture's most recent investment shown here?
Miracle Light Venture's most recent investment in this portfolio sample was in FlashDx Inc. in 2019.
What sectors does Miracle Light Venture focus on?
Miracle Light Venture focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Miracle Light Venture focus on?
Miracle Light Venture typically invests at the Early stage.